Clinical Trial Update: Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety studies of SHR4640 in subjects with moderate renal impairment and healthy volunteers have been completed. The study investiga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hyperuricemia | Phase 1 | Status: COMPLETED